2028 年亚太地区即时诊断市场预测 - COVID-19 影响和区域分析，按应用（传染病、心脏标志物、肿瘤标志物、非处方诊断测试、滥用药物、血气检测、生育力测试、尿液分析、凝血、血液学、血糖监测、门诊化学、分散临床化学和其他应用）和最终用户（专业诊断中心、家庭护理、研究实验室和最终用户）和国家/地区划分
No. of Pages: 160 | Report Code: TIPRE00026067 | Category: Life Sciences
No. of Pages: 160 | Report Code: TIPRE00026067 | Category: Life Sciences
癌症等疾病的医疗需求大量未得到满足、糖尿病、心血管和传染病以及患者和医生对这些疾病早期诊断的认识不断提高，推动了亚太地区护理诊断市场的发展。亚太地区的糖尿病患病率不断上升，因此为即时血糖检测领域创造了广泛的患者基础。据国际糖尿病联合会统计，2019年，东南亚（SEA）地区约有8800万成年人患有糖尿病，并且东南亚地区超过一半的糖尿病患者（57%）未被诊断。即时检测 (POCT) 在诊断、治疗和预防传染病方面发挥着至关重要的作用。 POC 检测可用于检测多种主要病原体，包括疟疾寄生虫、人类免疫缺陷病毒 (HIV)、人乳头瘤病毒 (HPV)、登革热、埃博拉病毒和寨卡病毒以及结核分枝杆菌（TB 细菌）。此外，医疗保健相关感染（HAI），例如中心静脉导管相关血流感染和导管相关尿路感染，可能会影响医院和其他医疗机构的患者。根据 NCBI 2020 年发布的一项最新研究，HAI 每年导致亚太地区约 1600 万个额外的住院天数。此外，根据同一项研究，HAI 每年会造成约 85 亿美元的额外财务负担。此外，COVID-19 大流行导致越来越多地采用现场诊断，这进一步推动了市场的发展。
亚太地区不断发展的医疗保健基础设施正在为主要市场参与者扩大业务创造重大机会。这可能是预测期内促进市场增长的主要因素。大多数主要参与者都集中在印度和中国等发展中国家，因为这些国家有大量人口患有艾滋病毒和其他传染病。此外，产品发布数量的增加表明了采用先进护理点诊断套件的潜在环境，这为市场增长提供了重大机会。例如，2020 年 11 月，雅培实验室宣布在印度推出 FreeStyle Libre 血糖监测系统。新设备采用了连续测量血糖水平的技术，并在任何时间点提供实时测量结果。
此外，各种会议举办活动的目的是让人们了解设备，并概述在建立和维护即时检测 (POCT) 服务时应应用的共同关键原则。这些会议/活动的参与者可以利用这些知识来开发一个引入 POCT 的框架，以满足与其家庭实践相关的特定临床需求。例如，2018 年 11 月，SELECTBIO 在台湾组织了亚洲诊断峰会，重点关注护理点诊断、在全球范围内部署的快速低成本诊断、癌症液体活检以及针对与癌症相关的各种分析物类别的免疫测定的开发。诊断。因此，由于亚洲国家医疗保健环境的意识增强和进步，对护理点诊断的需求增加，预计将为预测期内护理点诊断市场的参与者提供显着的增长机会。< /span>
亚太地区护理诊断市场参与者的合作、产品创新和技术合作等各种业务战略弥合了供需缺口。
< p>Strategic insights for Asia Pacific Point-of-Care Diagnostic involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 6,799.86 Million |
| Market Size by 2028 | US$ 16,188.31 Million |
| Global CAGR (2021 - 2028) | 13.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Point-of-Care Diagnostic refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Point-of-Care Diagnostic Market is valued at US$ 6,799.86 Million in 2021, it is projected to reach US$ 16,188.31 Million by 2028.
As per our report Asia Pacific Point-of-Care Diagnostic Market, the market size is valued at US$ 6,799.86 Million in 2021, projecting it to reach US$ 16,188.31 Million by 2028. This translates to a CAGR of approximately 13.2% during the forecast period.
The Asia Pacific Point-of-Care Diagnostic Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Point-of-Care Diagnostic Market report:
The Asia Pacific Point-of-Care Diagnostic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Point-of-Care Diagnostic Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Point-of-Care Diagnostic Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Point-of-Care Diagnostic Market
